The role of IL-1B in breast cancer bone metastasis

Endocrine-related Cancer
Claudia Tulotta, Penelope Ottewell

Abstract

Approximately 75% of patients with late-stage breast cancer will develop bone metastasis. This condition is currently considered incurable and patients' life expectancy is limited to 2-3 years following diagnosis of bone involvement. Interleukin (IL)-1B is a pro-inflammatory cytokine whose expression in primary tumours has been identified as a potential biomarker for predicting breast cancer patients at increased risk for developing bone metastasis. In this review, we discuss how IL-1B from both the tumour cells and the tumour microenvironment influence growth of primary breast tumours, dissemination into the bone metastatic niche and proliferation into overt metastases. Recent evidence indicates that targeting IL-1B signalling may provide promising new treatments that can hold tumour cells in a dormant state within bone thus preventing formation of overt bone metastases.

References

Jun 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·R PacificiL V Avioli
Jun 10, 1998·Cytokine & Growth Factor Reviews·C A Dinarello
Apr 12, 2000·Investigational New Drugs·J Nemunaitis
Feb 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·Elena VoronovRon N Apte
May 20, 2004·Rheumatology·V Strand, A F Kavanaugh
Oct 10, 2006·Vitamins and Hormones·Ichiro Nakamura, Eijiro Jimi
Apr 9, 2008·Archives of Biochemistry and Biophysics·Brendan F Boyce, Lianping Xing
Jul 4, 2009·Cancer Cell·Xiang H-F ZhangJoan Massagué
Jul 22, 2009·International Journal of Cancer. Journal International Du Cancer·Penelope D OttewellIngunn Holen
Jan 21, 2010·Science Signaling·Axel WeberMichael Kracht
Jan 25, 2011·Nature Reviews. Cancer·Giulio FranciaRobert S Kerbel
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
May 20, 2011·Nature Reviews. Cancer·Katherine N WeilbaecherLaurie K McCauley
Jul 27, 2011·Trends in Pharmacological Sciences·David BroughStuart M Allan
Aug 10, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Anjali MishraRussell S Taichman
Oct 15, 2011·The New England Journal of Medicine·Robert E ColemanUNKNOWN AZURE Investigators
Aug 2, 2012·Nature Reviews. Drug Discovery·Charles A DinarelloJos W M van der Meer
Mar 12, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yaron CarmiElena Voronov
Dec 18, 2013·Immunity·Cecilia GarlandaAlberto Mantovani
Jan 16, 2014·Annual Review of Medicine·Adriana A Jesus, Raphaela Goldbach-Mansky
Apr 2, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Penelope D OttewellIngunn Holen
Apr 3, 2014·Developmental and Comparative Immunology·Nikolay V OgryzkoHeather L Wilson
May 9, 2014·International Journal of Cancer. Journal International Du Cancer·Manja WobusMartin Bornhäuser
Jun 24, 2014·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Ning WangColby L Eaton
Jul 24, 2014·Endocrine-related Cancer·Penelope D OttewellIngunn Holen
Aug 8, 2014·PloS One·Sujeeve JeganathanRene E Harrison
Aug 29, 2014·Journal of Cellular Biochemistry·Eric Cordeiro-SpinettiAlex Balduino
Jan 22, 2015·International Journal of Cancer. Journal International Du Cancer·Penelope D OttewellIngunn Holen
Mar 10, 2015·Clinical & Experimental Metastasis·Donna M SosnoskiAndrea M Mastro
May 9, 2015·Mediators of Inflammation·Piero RuscittiRoberto Giacomelli
Aug 14, 2015·Cancer Research·Russell HughesClaire E Lewis
Aug 16, 2015·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Guangwen RenYibin Kang

❮ Previous
Next ❯

Citations

Feb 9, 2019·Anti-cancer Agents in Medicinal Chemistry·José R SantinNara L M Quintão
May 8, 2020·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Kyung-Hun LeeSeock-Ah Im
Jun 4, 2020·Journal for Immunotherapy of Cancer·Yong LiDaping Fan
Jul 2, 2020·Cells·Yulia Liubomirski, Adit Ben-Baruch
Sep 11, 2019·Journal of Hematology & Oncology·Qi WuShengrong Sun
Feb 20, 2019·International Journal of Molecular Sciences·Catarina Roma-RodriguesAlexandra R Fernandes
Oct 6, 2020·Journal of Immunology Research·Liliana R BalahuraMarieta Costache
Aug 12, 2020·Journal of Experimental & Clinical Cancer Research : CR·Rosamaria LappanoMarcello Maggiolini
Feb 13, 2021·Cancers·Rania F ZaarourSalem Chouaib
Dec 20, 2020·Cancers·Stephanie AnnettTracy Robson
Dec 17, 2020·Frontiers in Immunology·Peter C HartLawrence A Potempa
Mar 19, 2021·Frontiers in Cell and Developmental Biology·Peijie WuNa Xie
Mar 22, 2021·Hematology/oncology and Stem Cell Therapy·Ragini Yeeravalli, Amitava Das
Mar 30, 2021·Frontiers in Bioengineering and Biotechnology·Indira SigdelYuan Tang
May 22, 2021·Proceedings of the National Academy of Sciences of the United States of America·Anjan K PradhanPaul B Fisher
Jun 3, 2021·International Journal of Molecular Sciences·Andy GöbelTilman D Rachner

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
biopsies
xenografts

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.